Robeco Institutional Asset Management B.V. Has $42.06 Million Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Robeco Institutional Asset Management B.V. boosted its holdings in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 18.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,370 shares of the medical instruments supplier's stock after acquiring an additional 5,234 shares during the period. Robeco Institutional Asset Management B.V. owned about 0.16% of Mettler-Toledo International worth $42,058,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. DT Investment Partners LLC raised its holdings in shares of Mettler-Toledo International by 13.3% during the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier's stock valued at $102,000 after buying an additional 8 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Mettler-Toledo International by 8.0% during the third quarter. UMB Bank n.a. now owns 122 shares of the medical instruments supplier's stock valued at $183,000 after buying an additional 9 shares during the last quarter. Suncoast Equity Management increased its stake in shares of Mettler-Toledo International by 2.0% during the third quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier's stock valued at $690,000 after acquiring an additional 9 shares during the period. Bleakley Financial Group LLC increased its stake in shares of Mettler-Toledo International by 1.2% during the third quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier's stock valued at $1,135,000 after acquiring an additional 9 shares during the period. Finally, Huntington National Bank increased its stake in shares of Mettler-Toledo International by 20.0% during the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier's stock valued at $81,000 after acquiring an additional 9 shares during the period. Institutional investors own 95.07% of the company's stock.

Analysts Set New Price Targets

MTD has been the topic of a number of research analyst reports. Stifel Nicolaus lowered their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a research note on Monday, November 11th. Evercore ISI upgraded shares of Mettler-Toledo International from an "in-line" rating to an "outperform" rating and lifted their price target for the stock from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They issued a "peer perform" rating on the stock. Citigroup upgraded shares of Mettler-Toledo International from a "sell" rating to a "neutral" rating and lifted their price target for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Finally, Robert W. Baird decreased their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating on the stock in a research report on Monday, November 11th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $1,351.25.

Mettler-Toledo International Stock Up 2.3 %

Shares of NYSE:MTD traded up $30.50 during trading on Thursday, reaching $1,366.00. 23,740 shares of the company traded hands, compared to its average volume of 110,592. The firm has a fifty day simple moving average of $1,260.70 and a 200 day simple moving average of $1,343.47. The firm has a market cap of $28.82 billion, a P/E ratio of 36.83, a price-to-earnings-growth ratio of 4.19 and a beta of 1.12. Mettler-Toledo International Inc. has a 1-year low of $1,133.46 and a 1-year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. As a group, research analysts anticipate that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the business's stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the transaction, the insider now owns 6 shares of the company's stock, valued at $7,524.54. The trade was a 95.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Elisha W. Finney sold 76 shares of the company's stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares of the company's stock, valued at $314,820. This represents a 24.05 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.